{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:10:15Z","timestamp":1790079015266,"version":"4.0.1"},"reference-count":114,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160532"],"award-info":[{"award-number":["82160532"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403353"],"award-info":[{"award-number":["82403353"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003996","name":"Kunming Medical University","doi-asserted-by":"publisher","award":["2024XKTDYS08"],"award-info":[{"award-number":["2024XKTDYS08"]}],"id":[{"id":"10.13039\/501100003996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2026,11,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>With improved prognosis in early HER2\u2010positive breast cancer, safely de\u2010escalating treatment is increasingly investigated to minimize overtreatment. This article focuses on neoadjuvant de\u2010escalation strategies for HER2\u2010positive breast cancer. There have been initiatives to shorten the duration of anti\u2010HER2 therapy or to reduce the use of chemotherapy agents. Predictive or prognostic biomarkers and imaging techniques might help to identify subsets of patients within HER2\u2010positive cancer with the best chance of responding to treatment and benefiting from de\u2010escalated treatment.<\/jats:p>","DOI":"10.1002\/ijc.70614","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T01:38:10Z","timestamp":1785289090000},"page":"2393-2402","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["De\u2010Escalation of Neoadjuvant Treatment for\n                    <scp>HER2<\/scp>\n                    \u2010Positive Breast Cancer"],"prefix":"10.1002","volume":"159","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3825-5223","authenticated-orcid":false,"given":"Yiyin","family":"Ma","sequence":"first","affiliation":[{"name":"Yunnan Key Laboratory of Breast Cancer Precision Medicine, The Second Department of Breast Surgery Breast Cancer Center of the Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, Peking University Cancer Hospital Yunnan  Kunming China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dedian","family":"Chen","sequence":"additional","affiliation":[{"name":"Yunnan Key Laboratory of Breast Cancer Precision Medicine, The Second Department of Breast Surgery Breast Cancer Center of the Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, Peking University Cancer Hospital Yunnan  Kunming China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Huang","sequence":"additional","affiliation":[{"name":"Yunnan Key Laboratory of Breast Cancer Precision Medicine, The Second Department of Breast Surgery Breast Cancer Center of the Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, Peking University Cancer Hospital Yunnan  Kunming China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.35278"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03502-3"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.19323"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21863"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0299-9"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2021.102229"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000001417"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-016-4006-6"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/1758835919833519"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/OP.21.00020"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j5913"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.08.017"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.11.016"},{"key":"e_1_2_9_15_1","unstructured":"National Comprehensive Cancer Network (NCCN) \u201cNCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Breast Cancer. Version 1 \u201d 2025."},{"key":"e_1_2_9_16_1","unstructured":"Research C for DE \u201cPathological Complete Response in Neoadjuvant Treatment of High\u2010Risk Early\u2010Stage Breast Cancer: Use as an Endpoint to Support Accelerated Approval \u201d 2020 https:\/\/www.fda.gov\/regulatory\u2010information\/search\u2010fda\u2010guidance\u2010documents\/pathological\u2010complete\u2010response\u2010neoadjuvant\u2010treatment\u2010high\u2010risk\u2010early\u2010stage\u2010breast\u2010cancer\u2010use."},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00435"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3492"},{"key":"e_1_2_9_19_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-066381","article-title":"Evaluation of Pathological Complete Response as Surrogate Endpoint in Neoadjuvant Randomised Clinical Trials of Early Stage Breast Cancer: Systematic Review and Meta\u2010Analysis","volume":"375","author":"Conforti F.","year":"2021","journal-title":"BMJ"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62422-8"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100433"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2016.11.002"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.686591"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70336-9"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)00163-7"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.3692"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45591-7"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-022-00579-0"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00565-1"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02708-3"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.08.346"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-0446"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.e12635"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00342-5"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00051-7"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00066"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30570-9"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.1371"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt182"},{"key":"e_1_2_9_40_1","unstructured":"National Comprehensive Cancer Network (NCCN) \u201cNCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Breast Cancer. Version 8 \u201d 2021."},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx494"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00159-0"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2014.12.005"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2020.1829484"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.515"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.0646"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.08.2255"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.9815"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01816"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.8027"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-0851"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-022-00504-z"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.588"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30001-9"},{"key":"e_1_2_9_55_1","unstructured":"M.Luca \u201cPalbociclib Plus Letrozole Versus Weekly Paclitaxel Both in Combination with Trastuzumab Plus Pertuzumab as Neoadjuvant Treatment for Patients With HR+\/HER2+ Early Breast Cancer: Primary Results From the Randomized Phase II TOUCH Trial (IBCSG 55\u201017) \u201d 2024 https:\/\/sabcs.org\/."},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30716-7"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00882"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.1932"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26019-y"},{"key":"e_1_2_9_60_1","unstructured":"AstraZeneca \u201cA Phase 3 Open\u2010Label Trial of Neoadjuvant Trastuzumab Deruxtecan (T\u2010DXd) Monotherapy or T\u2010DXd Followed by THP Compared to ddAC\u2010THP in Participants With High\u2010Risk HER2\u2010Positive Early\u2010Stage Breast Cancer (DESTINY\u2010Breast11) \u201d 2025 https:\/\/clinicaltrials.gov\/study\/NCT05113251."},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2025.02.011"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1097983"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147517"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0798-2"},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.2310"},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.SABCS21-P2-13-03"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2024-CT029"},{"key":"e_1_2_9_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(25)00097-X"},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23179952"},{"key":"e_1_2_9_70_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.1370"},{"key":"e_1_2_9_71_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-2717"},{"key":"e_1_2_9_72_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju152"},{"key":"e_1_2_9_73_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02181-3"},{"key":"e_1_2_9_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30021-9"},{"key":"e_1_2_9_75_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-23-4066"},{"key":"e_1_2_9_76_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33217"},{"key":"e_1_2_9_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2019.01.004"},{"key":"e_1_2_9_78_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-1705"},{"key":"e_1_2_9_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102362"},{"key":"e_1_2_9_80_1","article-title":"Circulating Tumor DNA Predicts the Response and Prognosis in Patients With Early Breast Cancer Receiving Neoadjuvant Chemotherapy","volume":"4","author":"Li S.","year":"2020","journal-title":"JCO Precision Oncology"},{"key":"e_1_2_9_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.11.007"},{"key":"e_1_2_9_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-024-00653-3"},{"key":"e_1_2_9_83_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-2521"},{"key":"e_1_2_9_84_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.55.2158"},{"key":"e_1_2_9_85_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw434"},{"key":"e_1_2_9_86_1","doi-asserted-by":"publisher","DOI":"10.1177\/11782234241288671"},{"key":"e_1_2_9_87_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01741-x"},{"key":"e_1_2_9_88_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119360"},{"key":"e_1_2_9_89_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-2507"},{"key":"e_1_2_9_90_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-016-3837-5"},{"key":"e_1_2_9_91_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-017-4610-0"},{"key":"e_1_2_9_92_1","article-title":"Updates on Lymphovascular Invasion in Breast Cancer","volume":"11","author":"Kuhn E.","year":"2023","journal-title":"Biomedicine"},{"key":"e_1_2_9_93_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011647"},{"key":"e_1_2_9_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103773"},{"key":"e_1_2_9_95_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy414"},{"key":"e_1_2_9_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.08.182"},{"key":"e_1_2_9_97_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-40071-2"},{"key":"e_1_2_9_98_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx362.006"},{"key":"e_1_2_9_99_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.0830"},{"key":"e_1_2_9_100_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz055"},{"key":"e_1_2_9_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104320"},{"key":"e_1_2_9_102_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S253961"},{"key":"e_1_2_9_103_1","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.230082"},{"key":"e_1_2_9_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00104-9"},{"key":"e_1_2_9_105_1","doi-asserted-by":"publisher","DOI":"10.1177\/1010428317728285"},{"key":"e_1_2_9_106_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0189-1"},{"key":"e_1_2_9_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.07.2025"},{"key":"e_1_2_9_108_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.27246"},{"key":"e_1_2_9_109_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.740336"},{"key":"e_1_2_9_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70320-1"},{"key":"e_1_2_9_111_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00280"},{"key":"e_1_2_9_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00122-4"},{"key":"e_1_2_9_113_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-78865-3"},{"key":"e_1_2_9_114_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03267-1"},{"key":"e_1_2_9_115_1","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.230033"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.70614","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ijc.70614","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.70614","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:32:50Z","timestamp":1790076770000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.70614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":114,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,11,15]]}},"alternative-id":["10.1002\/ijc.70614"],"URL":"https:\/\/doi.org\/10.1002\/ijc.70614","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"2025-05-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}